Reading Time: 2 minutesIntroduction Chronic pain affects over 50 million American adults, with men comprising a significant portion due to occupational hazards, musculoskeletal injuries, and age-related degenerative conditions. In the United States, opioid prescriptions for pain management have surged, contributing to the ongoing crisis with over 100,000 overdose deaths annually as reported by the CDC. Testosterone cypionate, a long-acting intramuscular ester of testosterone, has emerged as a potential modulator in hypogonadal males experiencing refractory chronic pain. This article synthesizes preclinical, clinical, and epidemiological data evaluating its efficacy in reducing pain intensity and analgesic demands among American males, emphasizing its role in androgen replacement … Continue reading →